Latest filing published 28 Oct 2026 for XBiotech Inc., €634k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John Simard: trading record in brief
All filings by John Simard on record concern XBiotech Inc., in the capacity of chief executive. Over a trading history stretching from 17 March 2016 to 26 October 2026, the count stands at 29 filings.
The open-market side counts 1 purchase for €634k alongside 20 sales for €4.8M. The net balance comes to €4.2M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 3 option exercises. So far in 2026, the count stands at 1 purchase and no sales.
The newest entry dates from 28 October 2026: an open-market purchase of €634k, in XBiotech Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Simard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 368,524 shares@ US$1.93Common StockSEC:0001193125-26-435894:0Canonical exit: 24 Jan 2027 (T+90)
- 33,000 shares@ US$13.070.5% of flowCommon StockSEC:0001209191-22-009745:1
- 17,000 shares@ US$13.32189.6% of flowCommon StockSEC:0001209191-22-009745:0
- 18,000 shares@ US$12.770.3% of flowCommon StockSEC:0001209191-21-060523:1
- 10,875 shares@ US$12.830.2% of flowCommon StockSEC:0001209191-21-060523:2
- 21,125 shares@ US$12.900.3% of flowCommon StockSEC:0001209191-21-060523:3
- 39,286 shares@ US$12.4520.9% of flowCommon StockSEC:0001209191-21-060523:0
- 14,218 shares@ US$12.660.2% of flowCommon StockSEC:0001209191-21-059849:1
- 10,714 shares@ US$12.530.2% of flowCommon StockSEC:0001209191-21-059849:2
- 23,681 shares@ US$13.084913.2% of flowCommon StockSEC:0001209191-21-059849:0
- 16,396 shares@ US$13.410.3% of flowCommon StockSEC:0001209191-21-058475:1
- 18,558 shares@ US$13.070.3% of flowCommon StockSEC:0001209191-21-058475:2
- 19,684 shares@ US$13.230.3% of flowCommon StockSEC:0001209191-21-058475:3
- 6,263 shares@ US$14.26853.8% of flowCommon StockSEC:0001209191-21-058475:0
- 11,418 shares@ US$14.490.2% of flowCommon StockSEC:0001209191-21-057877:1
- 29,890 shares@ US$14.810.6% of flowCommon StockSEC:0001209191-21-057877:2
- 9,892 shares@ US$14.68056.1% of flowCommon StockSEC:0001209191-21-057877:0
- 16,860 shares@ US$15.240.3% of flowCommon StockSEC:0001209191-21-057295:1
- 19,669 shares@ US$15.140.4% of flowCommon StockSEC:0001209191-21-057295:2
- 13,471 shares@ US$15.0638.5% of flowCommon StockSEC:0001209191-21-057295:0
- 50,000 shares@ US$18.14737.9% of flowCommon StockSEC:0001209191-21-047105:0
- 500,000 shares@ US$7.504.6% of flowCommon SharesSEC:0001209191-21-022278:0
- 500,000 sharesCommon StockSEC:0001209191-20-051306:0
- 2,103,894 shares@ US$30.00Common StockSEC:0001209191-20-020220:0
- 2,016,466 shares@ US$30.0096.5% of flowCommon StockSEC:0001209191-20-009272:0
25 of 29 declarations